… Program Updates Ongoing clinical studies of sepofarsen for Leber Congenital Amaurosis 10 (LCA10), QR-421a for Usher … in the fall. Sepofarsen, lead clinical candidate for Leber congenital amaurosis 10 (LCA10) in the Phase 2/3 …
… treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis, today announced that Daniel de … treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis. Based on our unique proprietary …
… will be available for viewing until July 15, 2021. About Leber Congenital Amaurosis 10 (LCA10) Leber congenital amaurosis (LCA) is the most common cause of …
… include the following: Sepofarsen for CEP290 -mediated Leber congenital amaurosis 10 (LCA10): The Company expects to … disease target into preclinical development in 2022. About Leber Congenital Amaurosis 10 (LCA10) Leber congenital …
… trial of sepofarsen for the treatment of CEP290 -mediated Leber congenital amaurosis 10 (LCA10) did not meet its … 30 days following the presentation date. About Leber Congenital Amaurosis 10 (LCA10) Leber congenital amaurosis (LCA) is the most common cause of …
… Business Operations and Program Updates Sepofarsen for Leber congenital amaurosis 10 (LCA10): The Company expects to … statements appearing at the end of this release. About Leber Congenital Amaurosis 10 (LCA10) Leber congenital …
… 2/3 Illuminate trial of sepofarsen for CEP290-mediated Leber congenital amaurosis 10 (LCA10) did not meet the … later in H1 2022 on our website at www.proqr.com . About Leber Congenital Amaurosis 10 (LCA10) Leber congenital …
… and Program Updates Sepofarsen for CEP290-mediated Leber congenital amaurosis 10 (LCA10): The Company expects to … statements appearing at the end of this release. About Leber Congenital Amaurosis 10 (LCA10) Leber congenital …
… Program Updates Sepofarsen , lead clinical candidate for Leber congenital amaurosis 10 (LCA10): In January, the … later in Q1 2021 on our website at www.proqr.com . About Leber Congenital Amaurosis 10 (LCA10) Leber congenital …